Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-13

Clinical Trial Update: 7 Days of TD-4208 in Subjects With Chronic Obstructive Pulmonary Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for TD-4208 in COPD subjects; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TD-4208 (TD-4208)

Snippet

Sponsor: Mylan Inc. | Conditions: COPD | Phase 2 | Status: COMPLETED | Results posted: 2017-03-13